Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.83%
0%
-9.83%
6 Months
-15.07%
0%
-15.07%
1 Year
-20.91%
0%
-20.91%
2 Years
-23.32%
0%
-23.32%
3 Years
4.84%
0%
4.84%
4 Years
-28.63%
0%
-28.63%
5 Years
-0.05%
0%
-0.05%
Demant A/S for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.54%
EBIT Growth (5y)
29.16%
EBIT to Interest (avg)
8.07
Debt to EBITDA (avg)
2.24
Net Debt to Equity (avg)
1.30
Sales to Capital Employed (avg)
0.96
Tax Ratio
22.78%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
18.14%
ROE (avg)
28.37%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
5.51
EV to EBIT
15.51
EV to EBITDA
11.47
EV to Capital Employed
2.89
EV to Sales
2.86
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.63%
ROE (Latest)
28.77%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
22,549.00
19,503.00
15.62%
Operating Profit (PBDIT) excl Other Income
5,560.00
4,163.00
33.56%
Interest
559.00
195.00
186.67%
Exceptional Items
-218.00
-182.00
-19.78%
Consolidate Net Profit
2,555.00
2,276.00
12.26%
Operating Profit Margin (Excl OI)
187.40%
153.20%
3.42%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 15.62% vs 9.14% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 12.26% vs -16.05% in Dec 2022
About Demant A/S 
Demant A/S
Pharmaceuticals & Biotechnology
Demant A/S, formerly William Demant Holding A/S, is a Denmark-based company engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments, comprising operations of such audiometer companies as Interacoustics, Grason-Stadler, Amplivox, Maico and MedRx, and Personal Communication, which includes the business of Sennheiser Communications, a headset producer. The Company operates globally, through more than 90 subsidiaries and associates worldwide.
Company Coordinates 
Company Details
Kongebakken 9 , SMOERUM None : 2765
Registrar Details






